Home
About
Overview
Sharing Data
ORCID
Help
History (21)
Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461.
Granulocytic sarcoma of the testis.
Tracking and Failure Analysis of Explanted Neuromodulation Devices.
Brain Oxygen Optimization in Severe Traumatic Brain Injury Phase-II: A Phase II Randomized Trial.
Epigenetic Control of Cdkn2a.Arf Protects Tumor-Infiltrating Lymphocytes from Metabolic Exhaustion.
See All 21 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Epigenetic Control of Cdkn2a.Arf Protects Tumor-Infiltrating Lymphocytes from Metabolic Exhaustion.
Epigenetic Control of Cdkn2a.Arf Protects Tumor-Infiltrating Lymphocytes from Metabolic Exhaustion. Cancer Res. 2020 11 01; 80(21):4707-4719.
View in:
PubMed
subject areas
Animals
Cell Line, Tumor
Cyclin-Dependent Kinase Inhibitor p16
Enhancer of Zeste Homolog 2 Protein
Epigenesis, Genetic
Lymphocytes, Tumor-Infiltrating
Mice
Neoplasms, Experimental
Tumor Microenvironment
authors with profiles
Thomas Gajewski